Manning & Napier Group's BBIO Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 29 shares of BridgeBio Pharma, Inc. (BBIO) worth $2,088, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Manning & Napier Group has initiated a new position in BBIO, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's BridgeBio Pharma (BBIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly BridgeBio Pharma (BBIO) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +29 | New Buy | 29 | $72.00 |
Manning & Napier Group's BridgeBio Pharma Investment FAQs
Manning & Napier Group first purchased BridgeBio Pharma, Inc. (BBIO) in Q2 2026, acquiring 29 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held BridgeBio Pharma, Inc. (BBIO) for 1 quarters since Q2 2026.
Manning & Napier Group's largest addition to BridgeBio Pharma, Inc. (BBIO) was in Q2 2026, adding 29 shares worth $2,088.
According to the latest 13F filing for Q2 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 29 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $2,088.
As of the Q2 2026 filing, BridgeBio Pharma, Inc. (BBIO) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in BridgeBio Pharma, Inc. (BBIO) was 29 shares, as reported at the end of Q2 2026.